Axim Biotechnologies, Inc. SEC filings AXIM
Axim Biotechnologies, Inc. has 306 filings in SEC EDGAR's recent list, going back to Mar 10, 2011. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2024, covering the quarter ended Jun 30, 2024. The most recent current report (Form 8-K) was filed on Oct 15, 2024 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change in control, Officer or director change
|
Oct 15, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 21, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 13, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 28, 2023 | Dec 26, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 2, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
May 30, 2023 | May 23, 2023 |
| 8-K |
Current report
Officer or director change
|
May 25, 2023 | May 23, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 27, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 29, 2022 | Aug 29, 2022 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Mar 9, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Feb 16, 2022 | Feb 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 12, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 4, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Material agreement
|
May 14, 2021 | May 14, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 24, 2020 | Jul 21, 2020 |
| 8-K/A | Amended current report | May 29, 2020 | May 14, 2020 |
| 8-K |
Current report
Other events
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Officer or director change
|
May 12, 2020 | May 6, 2020 |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 27, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Mar 19, 2020 | Mar 17, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 8, 2020 | Jan 3, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 17, 2019 | Dec 16, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 9, 2019 | Jul 2, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 4, 2019 | May 31, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 23, 2019 | Apr 19, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 4, 2019 | Apr 2, 2019 |
| 8-K |
Current report
Change in control
|
Feb 26, 2019 | Feb 20, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2019 | Jan 15, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2019 | Jan 2, 2019 |
| 8-K |
Current report
Material agreement
|
Dec 7, 2018 | Nov 30, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 13, 2018 | Sep 10, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 27, 2018 | Aug 21, 2018 |
| 8-K |
Current report
Material agreement
|
May 11, 2018 | May 7, 2018 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2018 | Mar 30, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 5, 2018 | Apr 5, 2018 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Jun 26, 2017 | Jun 12, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 16, 2017 | Jun 12, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2017 | May 15, 2017 |
| 8-K |
Current report
Other events
|
May 15, 2017 | May 9, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 28, 2017 | Mar 28, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2017 | Mar 21, 2017 |
| 8-K |
Current report
Other events
|
Jan 19, 2017 | Jan 18, 2017 |
| 8-K |
Current report
Other events
|
Jan 10, 2017 | Dec 20, 2016 |
| 8-K |
Current report
Other events
|
Dec 30, 2016 | Dec 20, 2016 |
| 8-K |
Current report
Other events
|
Dec 13, 2016 | Dec 7, 2016 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2016 | Jun 29, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2016 | Feb 18, 2016 |
| 8-K |
Current report
Other events
|
Feb 8, 2016 | Jan 25, 2016 |
| 8-K |
Current report
Other events
|
Sep 1, 2015 | Aug 26, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2015 | Jul 31, 2015 |
| 8-K |
Current report
Other events
|
Jun 18, 2015 | Jun 18, 2015 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
May 14, 2015 | May 11, 2015 |
| 8-K |
Current report
Other events
|
Mar 24, 2015 | Mar 20, 2015 |
| 8-K |
Current report
Other events
|
Jan 28, 2015 | Dec 11, 2014 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2014 | Nov 25, 2014 |
| 8-K |
Current report
Other events
|
Nov 6, 2014 | Oct 14, 2014 |
| 8-K |
Current report
Auditor change
|
Jul 21, 2014 | Jul 16, 2014 |
| 8-K/A |
Amended current report
Change in control
|
Jun 9, 2014 | Mar 17, 2014 |
| 8-K/A |
Amended current report
Auditor change
|
May 29, 2014 | May 14, 2014 |
| 8-K |
Current report
Change in control
|
May 23, 2014 | Mar 17, 2014 |
| 8-K |
Current report
Auditor change
|
May 20, 2014 | May 14, 2014 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2014 | Mar 21, 2014 |
| 8-K |
Current report
Material agreement
|
Nov 29, 2012 | Nov 26, 2012 |
| 8-K |
Current report
Material agreement
|
Jul 25, 2012 | Jul 20, 2012 |
| 8-K |
Current report
Acquisition or sale of assets
|
Nov 1, 2011 | Oct 28, 2011 |
| 8-K |
Current report
Unregistered share sale
|
Oct 7, 2011 | Sep 30, 2011 |
Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXIM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514946
- Former names
- AXIM INTERNATIONAL INC. (until Aug 13, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.